AKTS·01021M104·US·equity-Activist
AKTS (AKTIS ONCOLOGY INC) is held by 45 institutional investors as of Q1 2026. Largest holders: WELLINGTON MANAGEMENT GROUP LLP ($41.5M), BlackRock, Inc. ($37.8M), RTW INVESTMENTS, LP ($28.5M). Net institutional sentiment: Bullish.
See how AKTS's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer